iBio (IBIO) Assets (2011 - 2026)
iBio (IBIO) posted quarterly Assets of $85.8 million for Q1 2026, up 349.32% year-over-year from $19.1 million in Q1 2025, and up 33.3% quarter-over-quarter from $64.4 million in Q4 2025.
iBio (IBIO) Assets (2011 - 2026) Analysis & Trends
iBio (IBIO) has reported Assets for 16 consecutive years, with $85.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Assets rose 349.32% year-over-year to $85.8 million; the TTM figure through Mar 2026 stood at $85.8 million (up 349.32% YoY), while the FY2025 annual figure was $23.2 million, down 19.31% from the prior year.
- Assets grew to $85.8 million in Q1 2026 per IBIO's latest filing, from $64.4 million in the prior quarter.
- Across five years, Assets topped out at $115.4 million in Q1 2022 and bottomed at $19.1 million in Q1 2025.
- Historically, Assets has averaged $52.4 million across 5 years, with a median of $44.4 million in 2023.
- Annual changes were most pronounced in 2025 — Assets slumped 61.91% — and 2026, when it jumped 349.32%.
- iBio's Assets stood at $51.8 million in 2022, then plunged by 34.32% to $34.0 million in 2023, then sank by 36.23% to $21.7 million in 2024, then jumped by 196.78% to $64.4 million in 2025, then surged by 33.3% to $85.8 million in 2026.
- Business Quant data shows IBIO's Assets at $85.8 million in Q1 2026, $64.4 million in Q4 2025, and $64.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 5.56 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 2.10 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.82 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 25.60 Bn |
| 10 | iBio | 175.21 Mn | 175.21 Mn | - | 85.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 85.83 Mn |
| Dec 31, 2025 | 64.39 Mn |
| Sep 30, 2025 | 64.16 Mn |
| Jun 30, 2025 | 23.19 Mn |
| Mar 31, 2025 | 19.10 Mn |
| Dec 31, 2024 | 21.70 Mn |
| Sep 30, 2024 | 24.52 Mn |
| Jun 30, 2024 | 28.73 Mn |
| Mar 31, 2024 | 50.15 Mn |
| Dec 31, 2023 | 34.02 Mn |
| Sep 30, 2023 | 37.68 Mn |
| Jun 30, 2023 | 41.21 Mn |
| Mar 31, 2023 | 44.39 Mn |
| Dec 31, 2022 | 51.80 Mn |
| Sep 30, 2022 | 84.56 Mn |
| Jun 30, 2022 | 99.41 Mn |
| Mar 31, 2022 | 115.37 Mn |
| Dec 31, 2021 | 126.45 Mn |
| Sep 30, 2021 | 143.74 Mn |
| Jun 30, 2021 | 146.97 Mn |